• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For May 11, 2023

    5/11/23 9:58:54 AM ET
    $RAIN
    $RCEL
    $REAX
    $RGTI
    Industrial Machinery/Components
    Technology
    Medical/Dental Instruments
    Health Care
    Get the next $RAIN alert in real time by email

    Companies Reporting Before The Bell

    • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter.

    • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its first quarter.

    • Addex Therapeutics (NASDAQ:ADXN) is projected to report earnings for its first quarter.

    • Fiverr Intl (NYSE:FVRR) is expected to report quarterly earnings at $0.24 per share on revenue of $87.66 million.

    • Teekay (NYSE:TK) is likely to report earnings for its first quarter.

    • Teekay Tankers (NYSE:TNK) is likely to report quarterly earnings at $4.38 per share on revenue of $243.55 million.

    • Pharming (NASDAQ:PHAR) is likely to report earnings for its first quarter.

    • Algonquin Power (NYSE:AQN) is expected to report quarterly earnings at $0.23 per share on revenue of $983.76 million.

    • Docebo (NASDAQ:DCBO) is projected to report quarterly earnings at $0.02 per share on revenue of $55.42 million.

    • Pioneer Muni High Inc (NYSE:MAV) is estimated to report quarterly loss at $0.04 per share on revenue of $25.67 million.

    • Mogo (NASDAQ:MOGO) is expected to report quarterly loss at $0.07 per share on revenue of $15.21 million.

    • JD.com (NASDAQ:JD) is estimated to report quarterly earnings at $0.50 per share on revenue of $34.64 billion.

    • Autohome (NYSE:ATHM) is projected to report quarterly earnings at $0.50 per share on revenue of $216.33 million.

    • Brookfield (NYSE:BN) is projected to report quarterly earnings at $0.92 per share on revenue of $29.31 billion.

    • TORM (NASDAQ:TRMD) is estimated to report quarterly earnings at $2.23 per share on revenue of $270.60 million.

    • YETI Holdings (NYSE:YETI) is estimated to report quarterly earnings at $0.16 per share on revenue of $294.63 million.

    • Fennec Pharmaceuticals (NASDAQ:FENC) is projected to report quarterly loss at $0.21 per share on revenue of $1.85 million.

    • Stronghold Digital Mining (NASDAQ:SDIG) is expected to report quarterly loss at $0.14 per share on revenue of $18.89 million.

    • Theriva Biologics (AMEX:TOVX) is projected to report earnings for its first quarter.

    • Park Aerospace (NYSE:PKE) is likely to report earnings for its fourth quarter.

    • Compass Pathways (NASDAQ:CMPS) is expected to report earnings for its first quarter.

    • National Vision Holdings (NASDAQ:EYE) is estimated to report quarterly earnings at $0.29 per share on revenue of $551.64 million.

    • S&W Seed (NASDAQ:SANW) is projected to report quarterly loss at $0.07 per share on revenue of $22.00 million.

    • Altimmune (NASDAQ:ALT) is expected to report earnings for its first quarter.

    • Veru (NASDAQ:VERU) is projected to report quarterly loss at $0.33 per share on revenue of $4.32 million.

    • HOOKIPA Pharma (NASDAQ:HOOK) is expected to report quarterly loss at $0.23 per share on revenue of $4.39 million.

    • Hut 8 Mining (NASDAQ:HUT) is expected to report quarterly loss at $0.15 per share on revenue of $21.20 million.

    • Moleculin Biotech (NASDAQ:MBRX) is expected to report earnings for its first quarter.

    • Dare Bioscience (NASDAQ:DARE) is likely to report quarterly loss at $0.10 per share on revenue of $1.67 million.

    • RVL Pharmaceuticals (NASDAQ:RVLP) is projected to report quarterly loss at $0.12 per share on revenue of $9.44 million.

    • Better Therapeutics (NASDAQ:BTTX) is projected to report earnings for its first quarter.

    • Virios Therapeutics (NASDAQ:VIRI) is estimated to report earnings for its first quarter.

    • Revvity (NYSE:PKI) is likely to report quarterly earnings at $1.06 per share on revenue of $751.04 million.

    • Telefonica (NYSE:TEF) is likely to report earnings for its first quarter.

    • KT (NYSE:KT) is expected to report earnings for its first quarter.

    • Milestone Scientific (AMEX:MLSS) is likely to report quarterly loss at $0.03 per share on revenue of $2.12 million.

    • eMagin (AMEX:EMAN) is likely to report quarterly loss at $0.01 per share on revenue of $7.56 million.

    • Telesat (NASDAQ:TSAT) is likely to report earnings for its first quarter.

    • Geron (NASDAQ:GERN) is projected to report quarterly loss at $0.10 per share on revenue of $80 thousand.

    • LiqTech Intl (NASDAQ:LIQT) is estimated to report quarterly loss at $0.04 per share on revenue of $4.00 million.

    • Utz Brands (NYSE:UTZ) is projected to report quarterly earnings at $0.10 per share on revenue of $352.45 million.

    • OmniAb (NASDAQ:OABI) is expected to report quarterly loss at $0.03 per share on revenue of $18.98 million.

    • Janus Intl Gr (NYSE:JBI) is projected to report quarterly earnings at $0.17 per share on revenue of $242.66 million.

    • Sonida Senior Living (NYSE:SNDA) is likely to report earnings for its first quarter.

    • Imunon (NASDAQ:IMNN) is expected to report earnings for its first quarter.

    • Energy Focus (NASDAQ:EFOI) is projected to report earnings for its first quarter.

    • CorEnergy Infr Tr (NYSE:CORR) is expected to report earnings for its first quarter.

    • DarioHealth (NASDAQ:DRIO) is estimated to report quarterly loss at $0.50 per share on revenue of $6.70 million.

    • ProPhase Labs (NASDAQ:PRPH) is likely to report quarterly loss at $0.09 per share on revenue of $16.30 million.

    • VerifyMe (NASDAQ:VRME) is projected to report quarterly loss at $0.09 per share on revenue of $5.50 million.

    • Live Ventures (NASDAQ:LIVE) is likely to report quarterly earnings at $2.21 per share on revenue of $100.00 million.

    • Kopin (NASDAQ:KOPN) is expected to report quarterly loss at $0.03 per share on revenue of $9.79 million.

    • UroGen Pharma (NASDAQ:URGN) is projected to report quarterly loss at $1.33 per share on revenue of $17.18 million.

    • ReWalk Robotics (NASDAQ:RWLK) is estimated to report quarterly loss at $0.08 per share on revenue of $2.00 million.

    • Superior Drilling Prods (AMEX:SDPI) is expected to report quarterly earnings at $0.02 per share on revenue of $5.45 million.

    • Marinus Pharma (NASDAQ:MRNS) is expected to report quarterly loss at $0.72 per share on revenue of $5.88 million.

    • Compx Intl (AMEX:CIX) is likely to report quarterly earnings at $0.77 per share on revenue of $626.36 million.

    • Real Brokerage (NASDAQ:REAX) is expected to report quarterly loss at $0.02 per share on revenue of $86.60 million.

    • Priority Tech Holdings (NASDAQ:PRTH) is expected to report quarterly loss at $0.14 per share on revenue of $171.28 million.

    • Bioventus (NASDAQ:BVS) is likely to report quarterly loss at $0.15 per share on revenue of $116.58 million.

    • Gogoro (NASDAQ:GGR) is expected to report earnings for its first quarter.

    • Chemomab Therapeutics (NASDAQ:CMMB) is projected to report earnings for its first quarter.

    • Sotherly Hotels (NASDAQ:SOHO) is likely to report earnings for its first quarter.

    • US Foods Hldg (NYSE:USFD) is expected to report quarterly earnings at $0.42 per share on revenue of $8.49 billion.

    • Kelly Services (NASDAQ:KELYB) is expected to report quarterly earnings at $0.30 per share on revenue of $1.23 billion.

    • OptiNose (NASDAQ:OPTN) is likely to report quarterly loss at $0.14 per share on revenue of $9.95 million.

    • Dynatronics (NASDAQ:DYNT) is estimated to report quarterly loss at $0.16 per share on revenue of $10.40 million.

    • Apyx Medical (NASDAQ:APYX) is likely to report quarterly loss at $0.13 per share on revenue of $10.87 million.

    • Olink Holding (NASDAQ:OLK) is estimated to report quarterly loss at $0.12 per share on revenue of $27.27 million.

    • Blade Air Mobility (NASDAQ:BLDE) is expected to report quarterly loss at $0.21 per share on revenue of $40.51 million.

    • P & F Industries (NASDAQ:PFIN) is expected to report earnings for its first quarter.

    • AcuityAds Holdings (NASDAQ:ILLM) is likely to report quarterly loss at $0.05 per share on revenue of $17.72 million.

    • Broadwind (NASDAQ:BWEN) is likely to report quarterly loss at $0.05 per share on revenue of $47.38 million.

    • Nova (NASDAQ:NVMI) is projected to report quarterly earnings at $1.04 per share on revenue of $130.06 million.

    • Bakkt Hldgs (NYSE:BKKT) is estimated to report quarterly loss at $0.18 per share on revenue of $14.35 million.

    • Holley (NYSE:HLLY) is likely to report quarterly earnings at $0.01 per share on revenue of $163.67 million.

    • NETSOL Technologies (NASDAQ:NTWK) is projected to report earnings for its third quarter.

    • Euronav (NYSE:EURN) is estimated to report quarterly earnings at $0.72 per share on revenue of $313.64 million.

    • Codere Online Luxembourg (NASDAQ:CDRO) is expected to report earnings for its first quarter.

    • Aveanna Healthcare Hldgs (NASDAQ:AVAH) is expected to report quarterly loss at $0.06 per share on revenue of $452.03 million.

    • OncoCyte (NASDAQ:OCX) is expected to report quarterly loss at $0.08 per share on revenue of $350 thousand.

    • Clearside Biomedical (NASDAQ:CLSD) is expected to report quarterly loss at $0.14 per share on revenue of $140 thousand.

    • ADS-TEC Energy (NASDAQ:ADSE) is likely to report quarterly loss at $0.77 per share on revenue of $68.30 million.

    • Westwater Resources (AMEX:WWR) is projected to report earnings for its first quarter.

    • Marketwise (NASDAQ:MKTW) is estimated to report quarterly earnings at $0.00 per share on revenue of $110.44 million.

    • Butterfly Network (NYSE:BFLY) is projected to report quarterly loss at $0.21 per share on revenue of $15.80 million.

    • Circor Intl (NYSE:CIR) is likely to report quarterly earnings at $0.13 per share on revenue of $190.60 million.

    • MiNK Therapeutics (NASDAQ:INKT) is estimated to report earnings for its first quarter.

    • Tapestry (NYSE:TPR) is estimated to report quarterly earnings at $0.59 per share on revenue of $1.44 billion.

    • Kelly Services (NASDAQ:KELYA) is projected to report quarterly earnings at $0.30 per share on revenue of $1.23 billion.

    • Katapult Holdings (NASDAQ:KPLT) is projected to report quarterly loss at $0.10 per share on revenue of $53.40 million.

    • Enlight Renewable Energy (NASDAQ:ENLT) is estimated to report quarterly earnings at $0.13 per share on revenue of $66.18 million.

    • PGT Innovations (NYSE:PGTI) is estimated to report quarterly earnings at $0.44 per share on revenue of $377.11 million.

    • CyberArk Software (NASDAQ:CYBR) is estimated to report quarterly loss at $0.26 per share on revenue of $162.48 million.

    • Carrols Restaurant Group (NASDAQ:TAST) is likely to report quarterly loss at $0.26 per share on revenue of $423.43 million.

    • Charles River (NYSE:CRL) is estimated to report quarterly earnings at $2.59 per share on revenue of $986.35 million.

    • Entegris (NASDAQ:ENTG) is likely to report quarterly earnings at $0.52 per share on revenue of $892.67 million.

    • Krispy Kreme (NASDAQ:DNUT) is likely to report quarterly earnings at $0.07 per share on revenue of $401.61 million.

    • Himax Techs (NASDAQ:HIMX) is expected to report quarterly earnings at $0.07 per share on revenue of $226.13 million.

    • NICE (NASDAQ:NICE) is expected to report quarterly earnings at $1.98 per share on revenue of $564.80 million.

    • Haemonetics (NYSE:HAE) is projected to report quarterly earnings at $0.70 per share on revenue of $289.64 million.

    • 1-800-Flowers.com (NASDAQ:FLWS) is projected to report quarterly loss at $0.36 per share on revenue of $426.84 million.

    Companies Reporting After The Bell

    • AuthID (NASDAQ:AUID) is expected to report earnings for its first quarter.

    • Harrow Health (NASDAQ:HROW) is likely to report quarterly loss at $0.05 per share on revenue of $25.15 million.

    • StarTek (NYSE:SRT) is estimated to report quarterly earnings at $0.06 per share on revenue of $89.23 million.

    • Vinci Partners Inv (NASDAQ:VINP) is projected to report quarterly earnings at $0.23 per share on revenue of $21.41 million.

    • Sun Life Financial (NYSE:SLF) is estimated to report quarterly earnings at $1.13 per share on revenue of $787.76 million.

    • Adecoagro (NYSE:AGRO) is expected to report earnings for its first quarter.

    • Vasta Platform (NASDAQ:VSTA) is estimated to report quarterly earnings at $0.05 per share on revenue of $81.44 million.

    • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.08 per share on revenue of $6.43 million.

    • Getty Images Holdings (NYSE:GETY) is projected to report quarterly earnings at $0.04 per share on revenue of $228.74 million.

    • Cresud SACIF (NASDAQ:CRESY) is projected to report earnings for its third quarter.

    • RiceBran Tech (NASDAQ:RIBT) is projected to report earnings for its first quarter.

    • Lument Finance Trust (NYSE:LFT) is projected to report quarterly earnings at $0.04 per share on revenue of $19.47 million.

    • UpHealth (NYSE:UPH) is expected to report quarterly loss at $0.63 per share on revenue of $36.27 million.

    • Relmada Therapeutics (NASDAQ:RLMD) is projected to report earnings for its first quarter.

    • Spero Therapeutics (NASDAQ:SPRO) is estimated to report quarterly loss at $0.33 per share on revenue of $1.00 million.

    • Shift Techs (NASDAQ:SFT) is expected to report quarterly loss at $2.53 per share on revenue of $57.23 million.

    • Motorsport Games (NASDAQ:MSGM) is projected to report quarterly loss at $3.35 per share on revenue of $1.34 million.

    • Agile Therapeutics (NASDAQ:AGRX) is likely to report quarterly loss at $7.50 per share on revenue of $3.40 million.

    • Trevi Therapeutics (NASDAQ:TRVI) is expected to report earnings for its first quarter.

    • Invivyd (NASDAQ:IVVD) is estimated to report earnings for its first quarter.

    • SilverCrest Metals (AMEX:SILV) is projected to report quarterly earnings at $0.13 per share on revenue of $39.73 million.

    • ImmuCell (NASDAQ:ICCC) is projected to report earnings for its first quarter.

    • NovaBay Pharmaceuticals (AMEX:NBY) is projected to report quarterly loss at $0.91 per share on revenue of $3.20 million.

    • Grove Collaborative Hldgs (NYSE:GROV) is projected to report quarterly loss at $0.08 per share on revenue of $69.95 million.

    • Pineapple Energy (NASDAQ:PEGY) is expected to report quarterly loss at $0.10 per share on revenue of $16.00 million.

    • Co-Diagnostics (NASDAQ:CODX) is estimated to report quarterly loss at $0.22 per share on revenue of $1.10 million.

    • Amylyx Pharma (NASDAQ:AMLX) is projected to report quarterly loss at $0.24 per share on revenue of $58.99 million.

    • ATA Creativity Glb (NASDAQ:AACG) is expected to report earnings for its first quarter.

    • Aytu BioPharma (NASDAQ:AYTU) is projected to report quarterly loss at $0.63 per share on revenue of $28.00 million.

    • Nuvve Holding (NASDAQ:NVVE) is expected to report quarterly loss at $0.41 per share on revenue of $1.20 million.

    • SenesTech (NASDAQ:SNES) is projected to report quarterly loss at $0.81 per share on revenue of $320 thousand.

    • iPath Series B Carbon Exchange-Traded Notes (NYSE:GRN) is expected to report quarterly loss at $0.01 per share on revenue of $17.59 million.

    • Eledon Pharma (NASDAQ:ELDN) is estimated to report earnings for its first quarter.

    • Biolase (NASDAQ:BIOL) is projected to report quarterly loss at $0.20 per share on revenue of $10.18 million.

    • Heron Therapeutics (NASDAQ:HRTX) is estimated to report quarterly loss at $0.20 per share on revenue of $29.69 million.

    • Helius Medical Tech (NASDAQ:HSDT) is likely to report quarterly loss at $0.11 per share on revenue of $280 thousand.

    • Ventyx Biosciences (NASDAQ:VTYX) is estimated to report earnings for its first quarter.

    • Silver Spike Investment (NASDAQ:SSIC) is estimated to report quarterly earnings at $0.17 per share on revenue of $800 thousand.

    • Eargo (NASDAQ:EAR) is projected to report quarterly loss at $1.90 per share on revenue of $7.60 million.

    • Westrock Coffee (NASDAQ:WEST) is projected to report quarterly loss at $0.01 per share on revenue of $219.23 million.

    • Faraday Future (NASDAQ:FFIE) is projected to report earnings for its first quarter.

    • Taysha Gene Therapies (NASDAQ:TSHA) is projected to report quarterly loss at $0.35 per share on revenue of $70 thousand.

    • Intuitive Machines (NASDAQ:LUNR) is estimated to report quarterly loss at $0.13 per share on revenue of $45.00 million.

    • Eyenovia (NASDAQ:EYEN) is estimated to report earnings for its first quarter.

    • SoundHound AI (NASDAQ:SOUN) is estimated to report quarterly loss at $0.12 per share on revenue of $6.72 million.

    • eGain (NASDAQ:EGAN) is expected to report quarterly earnings at $0.01 per share on revenue of $23.43 million.

    • Gritstone Bio (NASDAQ:GRTS) is estimated to report quarterly loss at $0.33 per share on revenue of $3.17 million.

    • Zomedica (AMEX:ZOM) is expected to report earnings for its first quarter.

    • Acorda Therapeutics (NASDAQ:ACOR) is projected to report earnings for its first quarter.

    • Smith Micro Software (NASDAQ:SMSI) is expected to report quarterly loss at $0.08 per share on revenue of $10.98 million.

    • Cyclacel Pharmaceuticals (NASDAQ:CYCC) is estimated to report earnings for its first quarter.

    • Journey Medical (NASDAQ:DERM) is expected to report quarterly loss at $0.45 per share on revenue of $16.18 million.

    • CuriosityStream (NASDAQ:CURI) is likely to report quarterly loss at $0.15 per share on revenue of $12.04 million.

    • Allied Gaming (NASDAQ:AGAE) is projected to report earnings for its first quarter.

    • Capricor Therapeutics (NASDAQ:CAPR) is estimated to report quarterly loss at $0.32 per share on revenue of $500 thousand.

    • Loop Media (AMEX:LPTV) is expected to report quarterly loss at $0.14 per share on revenue of $7.69 million.

    • Innodata (NASDAQ:INOD) is estimated to report earnings for its first quarter.

    • Clever Leaves Holdings (NASDAQ:CLVR) is projected to report quarterly loss at $0.15 per share on revenue of $3.60 million.

    • Lineage Cell Therapeutics (AMEX:LCTX) is estimated to report quarterly loss at $0.04 per share on revenue of $2.01 million.

    • Talis Biomedical (NASDAQ:TLIS) is projected to report quarterly loss at $0.73 per share on revenue of $250 thousand.

    • Issuer Direct (AMEX:ISDR) is expected to report quarterly earnings at $0.31 per share on revenue of $8.56 million.

    • Surgalign Holdings (NASDAQ:SRGA) is expected to report quarterly loss at $2.31 per share on revenue of $14.05 million.

    • Surgepays (NASDAQ:SURG) is expected to report quarterly loss at $0.03 per share on revenue of $36.50 million.

    • BioAtla (NASDAQ:BCAB) is likely to report earnings for its first quarter.

    • Rigetti Computing (NASDAQ:RGTI) is expected to report quarterly loss at $0.15 per share on revenue of $4.85 million.

    • Miromatrix Medical (NASDAQ:MIRO) is expected to report earnings for its first quarter.

    • Accelerate Diagnostics (NASDAQ:AXDX) is likely to report quarterly loss at $0.14 per share on revenue of $3.35 million.

    • Iamgold (NYSE:IAG) is estimated to report quarterly loss at $0.02 per share on revenue of $227.32 million.

    • Sangoma Technologies (NASDAQ:SANG) is estimated to report quarterly loss at $0.06 per share on revenue of $63.24 million.

    • Granite Ridge Resources (NYSE:GRNT) is expected to report earnings for its first quarter.

    • Markforged Holding (NYSE:MKFG) is expected to report quarterly loss at $0.08 per share on revenue of $22.92 million.

    • Indie Semiconductor (NASDAQ:INDI) is projected to report quarterly loss at $0.11 per share on revenue of $40.02 million.

    • Kingstone Companies (NASDAQ:KINS) is estimated to report quarterly loss at $0.19 per share on revenue of $25.06 million.

    • Rain Oncology (NASDAQ:RAIN) is estimated to report earnings for its first quarter.

    • Heritage Glb (NASDAQ:HGBL) is estimated to report quarterly earnings at $0.05 per share on revenue of $12.72 million.

    • AEye (NASDAQ:LIDR) is expected to report quarterly loss at $0.13 per share on revenue of $600 thousand.

    • Ouster (NYSE:OUST) is expected to report quarterly loss at $2.20 per share on revenue of $16.63 million.

    • SomaLogic (NASDAQ:SLGC) is projected to report quarterly loss at $0.22 per share on revenue of $18.02 million.

    • Archer Aviation (NYSE:ACHR) is estimated to report earnings for its first quarter.

    • Hyperfine (NASDAQ:HYPR) is estimated to report quarterly loss at $0.13 per share on revenue of $2.10 million.

    • IonQ (NYSE:IONQ) is estimated to report quarterly loss at $0.11 per share on revenue of $3.79 million.

    • 8x8 (NASDAQ:EGHT) is projected to report quarterly earnings at $0.09 per share on revenue of $185.51 million.

    • AVITA Medical (NASDAQ:RCEL) is expected to report quarterly loss at $0.25 per share on revenue of $10.33 million.

    • Direct Digital Holdings (NASDAQ:DRCT) is estimated to report quarterly loss at $0.08 per share on revenue of $17.05 million.

    • Quantum-Si (NASDAQ:QSI) is likely to report quarterly loss at $0.19 per share on revenue of $1.10 million.

    • Vitru (NASDAQ:VTRU) is projected to report quarterly earnings at $0.23 per share on revenue of $79.58 million.

    • Akili (NASDAQ:AKLI) is projected to report quarterly loss at $0.22 per share on revenue of $190 thousand.

    • Arcadia Biosciences (NASDAQ:RKDA) is likely to report quarterly loss at $6.85 per share on revenue of $1.40 million.

    • Sientra (NASDAQ:SIEN) is projected to report quarterly loss at $1.22 per share on revenue of $22.91 million.

    • Research Solutions (NASDAQ:RSSS) is expected to report quarterly loss at $0.01 per share on revenue of $9.82 million.

    • Phunware (NASDAQ:PHUN) is estimated to report quarterly loss at $0.07 per share on revenue of $5.38 million.

    • One Stop Systems (NASDAQ:OSS) is estimated to report quarterly earnings at $0.03 per share on revenue of $16.48 million.

    • LightPath Technologies (NASDAQ:LPTH) is expected to report quarterly loss at $0.03 per share on revenue of $7.17 million.

    • Leafly Holdings (NASDAQ:LFLY) is likely to report quarterly loss at $0.17 per share on revenue of $11.10 million.

    • Iridex (NASDAQ:IRIX) is estimated to report quarterly loss at $0.12 per share on revenue of $13.64 million.

    • Intrusion (NASDAQ:INTZ) is likely to report quarterly loss at $0.21 per share on revenue of $1.85 million.

    • Flux Power Holdings (NASDAQ:FLUX) is estimated to report quarterly loss at $0.10 per share on revenue of $16.34 million.

    • Eton Pharmaceuticals (NASDAQ:ETON) is expected to report quarterly loss at $0.14 per share on revenue of $4.56 million.

    • Brilliant Earth Group (NASDAQ:BRLT) is expected to report quarterly earnings at $0.02 per share on revenue of $95.22 million.

    • Momentus (NASDAQ:MNTS) is expected to report quarterly loss at $0.23 per share on revenue of $280 thousand.

    • Applied DNA Sciences (NASDAQ:APDN) is likely to report quarterly loss at $0.20 per share on revenue of $4.12 million.

    • News (NASDAQ:NWSA) is estimated to report quarterly earnings at $0.05 per share on revenue of $2.37 billion.

    • ClearPoint Neuro (NASDAQ:CLPT) is expected to report quarterly loss at $0.18 per share on revenue of $5.10 million.

    • TMC Metals (NASDAQ:TMC) is likely to report earnings for its first quarter.

    • Acutus Medical (NASDAQ:AFIB) is likely to report quarterly loss at $0.69 per share on revenue of $3.85 million.

    • BRC (NYSE:BRCC) is likely to report quarterly loss at $0.08 per share on revenue of $81.33 million.

    • Educational Development (NASDAQ:EDUC) is estimated to report earnings for its fourth quarter.

    • Thorne HealthTech (NASDAQ:THRN) is estimated to report quarterly earnings at $0.08 per share on revenue of $66.21 million.

    • Pulse Biosciences (NASDAQ:PLSE) is projected to report earnings for its first quarter.

    • Owlet (NYSE:OWLT) is estimated to report quarterly loss at $0.09 per share on revenue of $10.88 million.

    • Geospace Technologies (NASDAQ:GEOS) is likely to report earnings for its second quarter.

    • Nuburu (AMEX:BURU) is expected to report earnings for its first quarter.

    • Ellington Residential (NYSE:EARN) is estimated to report quarterly earnings at $0.24 per share on revenue of $3.17 million.

    • CTI BioPharma (NASDAQ:CTIC) is estimated to report quarterly loss at $0.12 per share on revenue of $22.95 million.

    • OppFi (NYSE:OPFI) is expected to report quarterly loss at $0.01 per share on revenue of $116.74 million.

    • News (NASDAQ:NWS) is expected to report earnings for its third quarter.

    • Cemtrex (NASDAQ:CETX) is likely to report earnings for its second quarter.

    • Aspira Womens Health (NASDAQ:AWH) is projected to report quarterly loss at $0.05 per share on revenue of $2.56 million.

    • Biodesix (NASDAQ:BDSX) is projected to report quarterly loss at $0.24 per share on revenue of $8.70 million.

    • TELA Bio (NASDAQ:TELA) is likely to report quarterly loss at $0.56 per share on revenue of $12.02 million.

    • Stepan (NYSE:SCL) is expected to report quarterly earnings at $0.16 per share on revenue of $332.54 million.

    • Airgain (NASDAQ:AIRG) is likely to report quarterly loss at $0.06 per share on revenue of $16.44 million.

    • Telesis Bio (NASDAQ:TBIO) is estimated to report quarterly loss at $0.37 per share on revenue of $7.40 million.

    • HireQuest (NASDAQ:HQI) is estimated to report quarterly earnings at $0.27 per share on revenue of $9.61 million.

    • Acacia Research (NASDAQ:ACTG) is estimated to report quarterly loss at $0.02 per share on revenue of $16.00 million.

    • BSQUARE (NASDAQ:BSQR) is likely to report earnings for its first quarter.

    • PhenomeX (NASDAQ:CELL) is estimated to report quarterly loss at $0.29 per share on revenue of $17.88 million.

    • Asensus Surgical (AMEX:ASXC) is estimated to report quarterly loss at $0.08 per share on revenue of $2.00 million.

    • Gen Digital (NASDAQ:GEN) is likely to report quarterly earnings at $0.44 per share on revenue of $940.05 million.

    • Arlo Technologies (NYSE:ARLO) is projected to report quarterly loss at $0.05 per share on revenue of $104.91 million.

    • Inotiv (NASDAQ:NOTV) is estimated to report quarterly loss at $0.42 per share on revenue of $133.29 million.

    • Sanmina (NASDAQ:SANM) is expected to report quarterly earnings at $1.55 per share on revenue of $2.25 billion.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $RAIN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RAIN
    $RCEL
    $REAX
    $RGTI

    CompanyDatePrice TargetRatingAnalyst
    Biodesix Inc.
    $BDSX
    2/27/2026Mkt Perform → Outperform
    William Blair
    Teekay Tankers Ltd.
    $TNK
    2/20/2026Buy → Hold
    DNB Markets
    YETI Holdings Inc.
    $YETI
    2/20/2026$54.00Neutral → Buy
    B. Riley Securities
    Fiverr International Ltd.
    $FVRR
    2/19/2026$15.00Overweight → Neutral
    Analyst
    Fiverr International Ltd.
    $FVRR
    2/19/2026$14.00Buy → Neutral
    Roth Capital
    Fiverr International Ltd.
    $FVRR
    2/18/2026Buy → Hold
    Needham
    YETI Holdings Inc.
    $YETI
    2/17/2026$60.00Neutral → Buy
    Roth Capital
    Tapestry Inc.
    $TPR
    2/13/2026$176.00Outperform
    BNP Paribas Exane
    More analyst ratings

    $RAIN
    $RCEL
    $REAX
    $RGTI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Biodesix upgraded by William Blair

    William Blair upgraded Biodesix from Mkt Perform to Outperform

    2/27/26 8:20:07 AM ET
    $BDSX
    Medical Specialities
    Health Care

    Teekay Tankers downgraded by DNB Markets

    DNB Markets downgraded Teekay Tankers from Buy to Hold

    2/20/26 8:23:03 AM ET
    $TNK
    Marine Transportation
    Consumer Discretionary

    YETI Holdings upgraded by B. Riley Securities with a new price target

    B. Riley Securities upgraded YETI Holdings from Neutral to Buy and set a new price target of $54.00

    2/20/26 8:21:13 AM ET
    $YETI
    Recreational Games/Products/Toys
    Consumer Discretionary

    $RAIN
    $RCEL
    $REAX
    $RGTI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Brookfield Property Partners Completes 2025 Annual Filings

    BROOKFIELD NEWS, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Brookfield Property Partners announced today that it has filed its 2025 annual report on Form 20-F, including its audited financial statements for the year ended December 31, 2025, with the SEC on EDGAR as well as with the Canadian securities authorities on SEDAR+. These documents are also available at bpy.brookfield.com. Brookfield Property Partners Brookfield Property Partners is one of the world's premier real estate companies. We own and operate iconic properties in the world's major markets, and our global portfolio includes office, retail, multifamily, logistics, hospitality, single-family rentals, manufactured housing, student hou

    2/27/26 6:23:18 PM ET
    $BN
    Building operators
    Real Estate

    Utz Brands Showcases New Chips, Pretzels and Bestsellers at Natural Products Expo West

    Boulder Canyon showcases innovation including tortilla chip lineup and new Boulder Batch Agave Sriracha Flavored Potato Chips and Utz debuts new line of Protein Pretzels and Cheese Curls Utz Brands, Inc., a leading U.S. manufacturer of branded salty snack foods will showcase new innovative products from Boulder Canyon® and Utz® at Booth 1117 in Hall A at the 2026 Natural Products Expo West, held March 4-6 at the Anaheim Convention Center in Anaheim, CA. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260227548219/en/Utz Brands Showcases New Chips, Pretzels and Bestsellers at Natural Products Expo West (Source: Utz Brands, Inc.)

    2/27/26 12:00:00 PM ET
    $UTZ
    Packaged Foods
    Consumer Staples

    Mach 2 and Beyond: Aerospace Enters Its Biggest Spending Cycle

    Issued on behalf of Starfighters SpaceVANCOUVER, BC, Feb. 27, 2026 /CNW/ -- Equity Insider News Commentary -- Congress approved $839 billion in Pentagon funding for fiscal 2026, $8 billion more than the Department of Defense requested, with billions earmarked for space, missile defense, and advanced aerospace systems[1]. The Pentagon's $152 billion reconciliation spending plan allocates $2.2 billion specifically to accelerate hypersonic defense systems and $5.6 billion for space-based interceptors[2]. Companies positioned across aerospace testing, defense technology, and space infrastructure include Starfighters Space (NYSE-A: FJET), Kratos Defense (NASDAQ:KTOS), V2X (NYSE:VVX), Redwire (NYS

    2/27/26 11:24:00 AM ET
    $FJET
    $KTOS
    $LUNR
    Air Freight/Delivery Services
    Consumer Discretionary
    Military/Government/Technical
    Industrials

    $RAIN
    $RCEL
    $REAX
    $RGTI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Teuber William J Jr bought $115,155 worth of shares (3,000 units at $38.38), increasing direct ownership by 47% to 9,413 units (SEC Form 4)

    4 - IonQ, Inc. (0001824920) (Issuer)

    2/27/26 9:55:03 PM ET
    $IONQ
    EDP Services
    Technology

    Director Hunt James Christopher bought $37,200 worth of shares (4,000 units at $9.30), increasing direct ownership by 15% to 29,976 units (SEC Form 4)

    4 - KELLY SERVICES INC (0000055135) (Issuer)

    2/26/26 4:41:15 PM ET
    $KELYB
    Professional Services
    Consumer Discretionary

    Director Hunt James Christopher bought $94,300 worth of shares (10,000 units at $9.43), increasing direct ownership by 63% to 25,976 units (SEC Form 4)

    4 - KELLY SERVICES INC (0000055135) (Issuer)

    2/25/26 4:45:02 PM ET
    $KELYB
    Professional Services
    Consumer Discretionary

    $RAIN
    $RCEL
    $REAX
    $RGTI
    SEC Filings

    View All

    Pulse Biosciences Inc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - PULSE BIOSCIENCES, INC. (0001625101) (Filer)

    2/27/26 5:26:13 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    IonQ Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - IonQ, Inc. (0001824920) (Filer)

    2/27/26 5:23:08 PM ET
    $IONQ
    EDP Services
    Technology

    SEC Form 424B7 filed by IonQ Inc.

    424B7 - IonQ, Inc. (0001824920) (Filer)

    2/27/26 5:15:43 PM ET
    $IONQ
    EDP Services
    Technology

    $RAIN
    $RCEL
    $REAX
    $RGTI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZYNRELEF KIT issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug ZYNRELEF KIT (SUPPL-18) with active ingredient BUPIVACAINE; MELOXICAM has changed to 'Approval' on 11/21/2024. Application Category: NDA, Application Number: 211988, Application Classification: Labeling

    11/22/24 4:36:11 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    November 14, 2024 - FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency

    For Immediate Release: November 14, 2024 The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and pediatric patients with aromatic L-amino acid decarboxylase (AADC) deficiency. Kebilidi is the first FDA-approved gene therapy for treatment of AADC deficiency. “Clinical advancements in the f

    11/14/24 8:50:18 AM ET
    $CLPT
    $PTCT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    $RAIN
    $RCEL
    $REAX
    $RGTI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Teuber William J Jr bought $115,155 worth of shares (3,000 units at $38.38), increasing direct ownership by 47% to 9,413 units (SEC Form 4)

    4 - IonQ, Inc. (0001824920) (Issuer)

    2/27/26 9:55:03 PM ET
    $IONQ
    EDP Services
    Technology

    Executive Chair, IonQ Federal Cardillo Robert T. exercised 2,500 shares at a strike of $11.24, sold $203,685 worth of shares (5,165 units at $39.44) and covered exercise/tax liability with 3,071 shares, decreasing direct ownership by 5% to 109,220 units (SEC Form 4)

    4 - IonQ, Inc. (0001824920) (Issuer)

    2/27/26 9:55:05 PM ET
    $IONQ
    EDP Services
    Technology

    Large owner Zoi Mike sold $86,951 worth of shares (24,024 units at $3.62) (SEC Form 4)

    4 - Motorsport Games Inc. (0001821175) (Issuer)

    2/27/26 6:23:34 PM ET
    $MSGM
    Computer Software: Prepackaged Software
    Technology

    $RAIN
    $RCEL
    $REAX
    $RGTI
    Financials

    Live finance-specific insights

    View All

    LiqTech International Announces Financial Results for Fourth Quarter and Full Year 2025

    BALLERUP, Denmark, Feb. 27, 2026 (GLOBE NEWSWIRE) -- LiqTech International, Inc. (NASDAQ:LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly specialized filtration technologies, today announces its financial results for the fourth quarter and fiscal year 2025 for the period ended December 31, 2025. Recent Financial Highlights FY 2025 revenue of $16.5 million, a 13% increase from $14.6 million in FY 2024. Q4 2025 revenue of $3.1 million, compared to $3.4 million in Q4 2024, an 8% decrease.FY 2025 net loss of $(8.6) million compared to $(10.3) million in FY 2024. Q4 2025 net loss of $(2.6) million compared to $(3.0) million in Q4 2024.FY 2025 Adjusted EBITDA

    2/27/26 8:00:00 AM ET
    $LIQT
    Industrial Machinery/Components
    Technology

    Docebo Reports Fourth Quarter and Fiscal Year 2025 Results

    Docebo Inc. (NASDAQ:DCBO, TSX:DCBO) ("Docebo" or the "Company"), a leading learning platform provider with a foundation in artificial intelligence (AI) and innovation, announced financial results for the three months and fiscal year ended December 31, 2025. All amounts are expressed in US dollars unless otherwise stated. "Q4 was one of Docebo's strongest quarters on record, with gross bookings performance being the strongest since 2021 and Adjusted EBITDA margins reaching 21.2%, both reflecting the compounding payoff of the AI-First strategy we've been executing against," said Alessio Artuffo, President and CEO of Docebo. "The caliber of enterprise customers who chose Docebo this quarter,

    2/27/26 6:00:00 AM ET
    $DCBO
    Computer Software: Prepackaged Software
    Technology

    SoundHound AI Reports Record Annual Revenue of $169 Million, Up Nearly 100%, Forecasts Strong Growth

    SANTA CLARA, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- SoundHound AI, Inc. (NASDAQ:SOUN), a global leader in voice and conversational AI, today reported its financial results for the fourth quarter and full year 2025. "As traditional software faces massive AI disruption, businesses are looking to partner with AI natives that can help them achieve success in a new era. This is creating strong tailwinds for SoundHound," said Keyvan Mohajer, CEO and Co-Founder of SoundHound AI. "Our results speak for themselves. All key profit metrics were up and in the last quarter we closed a record number of customer deals as we capitalized on the surge in demand for enterprise-grade AI." Financial Hig

    2/26/26 4:06:00 PM ET
    $SOUN
    Computer Software: Prepackaged Software
    Technology

    $RAIN
    $RCEL
    $REAX
    $RGTI
    Leadership Updates

    Live Leadership Updates

    View All

    Diality Appoints Peter Donato as Chief Financial Officer

    Life sciences veteran brings private and public sector expertise to company in midst of growth trajectory Diality Inc., a medical device company that has developed the Moda-flx™ Hemodialysis System, today announced it has named Peter Donato as its chief financial officer. Donato joins the company as it continues to enroll patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial of its Moda-flx Hemodialysis System while preparing for a limited market release in 2027. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224064413/en/Diality CFO Peter Donato. Donato joins Diality with nearly 35 years of financial leadershi

    2/24/26 7:05:00 AM ET
    $MYGN
    $STIM
    $TFX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Medical/Dental Instruments
    Pharmaceuticals and Biotechnology

    DentaQuest's Chief Dental Officer Named to TeamSmile Board of Directors

    Dr. Todd Gray's passion for oral healthcare aligns with Sun Life and TeamSmile missions to provide children in need with life-changing dental careWELLESLEY, Mass., Feb. 19, 2026 /PRNewswire/ -- Dr. Todd Gray, chief dental officer for Sun Life U.S. including DentaQuest, recently joined TeamSmile's Board of Directors, reinforcing both a personal and professional dedication to improving oral health for all. DentaQuest has been the exclusive national dental insurance partner of TeamSmile since 2017.TeamSmile is the nation's premier advocacy group that partners oral health profession

    2/19/26 10:00:00 AM ET
    $SLF
    Life Insurance
    Finance

    YETI Announces CFO Transition

    AUSTIN, Texas, Feb. 19, 2026 (GLOBE NEWSWIRE) -- YETI Holdings, Inc. ("YETI") (NYSE:YETI) today announced that Scott Bomar has been appointed Senior Vice President, Chief Financial Officer and Treasurer, effective February 23, 2026 (the "Effective Date"). Mr. Bomar succeeds Mike McMullen, who will cease to serve as YETI's Chief Financial Officer as of the Effective Date. Mr. McMullen will serve in an advisory capacity from the Effective Date until May 31, 2026 to facilitate a smooth transition. Mr. Bomar joins YETI from The Home Depot, Inc. ("Home Depot"), where he served in positions of increasing responsibility over nearly two decades, most recently serving as Senior Vice President of F

    2/19/26 6:00:00 AM ET
    $YETI
    Recreational Games/Products/Toys
    Consumer Discretionary

    $RAIN
    $RCEL
    $REAX
    $RGTI
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Investment Alert: Stock Acquired at Allied Gaming & Entertainment Inc. on Jul 4

    Recently, on July 4, 2024, a significant insider purchase was recorded at Allied Gaming & Entertainment Inc. as Large owner Choi Roy bought $456,750 worth of shares (360,000 units at $1.27), increasing direct ownership by 14% to 2,871,822 units (SEC Form 4). This purchase is notable for the size of the transaction and the percentage increase in direct ownership, indicating a strong belief in the company's future prospects. Insider purchases are generally viewed positively by investors as they signal confidence from those with intimate knowledge of the company's operations. Examining other recent insider transactions at Allied Gaming & Entertainment Inc., we notice a few patterns worth explo

    7/4/24 9:02:21 PM ET
    $AGAE
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $RAIN
    $RCEL
    $REAX
    $RGTI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Acutus Medical Inc.

    SC 13D/A - Acutus Medical, Inc. (0001522860) (Subject)

    12/16/24 9:52:56 PM ET
    $AFIB
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form SC 13D/A filed by Pioneer Municipal High Income Advantage Fund Inc.

    SC 13D/A - PIONEER MUNICIPAL HIGH INCOME ADVANTAGE FUND, INC. (0001258943) (Subject)

    12/13/24 4:29:08 PM ET
    $MAV
    Finance Companies
    Finance

    SEC Form SC 13G filed by DarioHealth Corp.

    SC 13G - DarioHealth Corp. (0001533998) (Subject)

    12/13/24 4:05:12 PM ET
    $DRIO
    Medical/Dental Instruments
    Health Care